HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 323 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,690,426 | -6.7% | 44,252 | -11.9% | 0.09% | -4.1% |
Q2 2023 | $1,811,471 | +28.4% | 50,221 | +36.0% | 0.10% | +11.5% |
Q1 2023 | $1,410,280 | +9.1% | 36,928 | +62.6% | 0.09% | +3.6% |
Q4 2022 | $1,292,313 | +43.4% | 22,712 | -0.3% | 0.08% | +29.2% |
Q3 2022 | $901,000 | -11.8% | 22,788 | -1.9% | 0.06% | 0.0% |
Q2 2022 | $1,022,000 | -5.8% | 23,230 | -14.7% | 0.06% | +41.3% |
Q1 2022 | $1,085,000 | -11.0% | 27,218 | -10.2% | 0.05% | +15.0% |
Q4 2021 | $1,219,000 | -12.0% | 30,312 | -11.0% | 0.04% | -14.9% |
Q3 2021 | $1,386,000 | +171.2% | 34,067 | +203.5% | 0.05% | +176.5% |
Q2 2021 | $511,000 | +12.3% | 11,223 | +2.8% | 0.02% | 0.0% |
Q1 2021 | $455,000 | -14.3% | 10,916 | -12.2% | 0.02% | -26.1% |
Q4 2020 | $531,000 | -2.2% | 12,427 | -80.3% | 0.02% | -11.5% |
Q2 2016 | $543,000 | -10.8% | 62,971 | -2.1% | 0.03% | -18.8% |
Q1 2016 | $609,000 | -56.2% | 64,341 | -19.8% | 0.03% | -51.5% |
Q4 2015 | $1,389,000 | +28.7% | 80,177 | -0.2% | 0.07% | +8.2% |
Q3 2015 | $1,079,000 | – | 80,356 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 1,129,551 | $51,293,000 | 7.24% |
First Light Asset Management, LLC | 2,050,273 | $93,103,000 | 5.59% |
TRAN CAPITAL MANAGEMENT, L.P. | 1,350,870 | $61,343,000 | 5.06% |
SNYDER CAPITAL MANAGEMENT L P | 3,176,404 | $144,241,000 | 4.04% |
DOHENY ASSET MANAGEMENT /CA | 91,930 | $4,175,000 | 2.69% |
Redwood Investments, LLC | 538,656 | $24,460,000 | 1.97% |
HighMark Wealth Management LLC | 53,457 | $2,427,000 | 1.78% |
Taylor Wealth Management Partners | 85,409 | $3,878,000 | 1.37% |
SILVERARC CAPITAL MANAGEMENT, LLC | 66,673 | $3,028,000 | 1.35% |
Granite Investment Partners, LLC | 919,029 | $41,733,000 | 1.29% |